Literature DB >> 3828971

Enhanced expression of four cellular oncogenes in a human glioblastoma cell line.

N Blin, R Müller-Brechlin, C Carstens, E Meese, K D Zang.   

Abstract

Examination of a human glioblastoma cell line displaying a relatively stable karyotype and absence of both copies of chromosome #13 (HeRo) as well as of a SV-40 transformed subline (HeRo-SV) using analysis on the DNA and RNA level showed that both cell lines express high levels of abl, erb B, myc, and Ha-ras mRNA. Neither gene amplification nor gene rearrangement at the loci concerned nor abnormal transcription account for this activation of expression. The possible influence of the deleted sequences in the context of a suppressor gene hypothesis is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3828971     DOI: 10.1016/0165-4608(87)90189-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy.

Authors:  C Haberler; E Gelpi; C Marosi; K Rössler; P Birner; H Budka; J A Hainfellner
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

2.  Loss of heterozygosity and the origin of meningioma.

Authors:  E Meese; N Blin; K D Zang
Journal:  Hum Genet       Date:  1987-12       Impact factor: 4.132

3.  Conserved cis-elements bind a protein complex that regulates Drosophila ras2/rop bidirectional expression.

Authors:  K Lightfoot; L Maltby; R Duarte; R Veale; O Segev
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

4.  Overexpression of multiple oncogenes related to histological grade of astrocytic glioma.

Authors:  J M Orian; K Vasilopoulos; S Yoshida; A H Kaye; C W Chow; M F Gonzales
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.